Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VTEB✓SelectedUSD · VTEBGSK vs VTEB performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs VTEB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+112.1%
VTEB return
+26.1%
Excess return
+85.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioVTEBExcessAlpha
1D-1.3%0.0%-1.3%-1.3%
7D-3.1%-1.6%-1.5%-1.8%
30D-0.9%+1.1%-2.0%-1.7%
3M-4.2%-1.5%-2.7%-2.9%
6M-1.6%-1.2%-0.3%-0.5%
YTD+2.6%-1.0%+3.6%+3.6%
1Y+6.2%-0.7%+6.9%+6.9%
3Y+55.0%+8.7%+46.3%+45.9%
5Y+42.8%+2.1%+40.7%+40.2%
10Y+102.1%+23.0%+79.1%+111.9%
All+112.1%+26.1%+85.9%+135.6%

Cumulative growth

Daily Returns

Daily percentage return beside VTEB.

Daily Out/Under-Performance

Portfolio return minus VTEB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VTEB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded VTEB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling